Dr. De Jong, MD, PhD, is a pediatric hematologist-oncologist and Associate Professor of Pediatrics on the Committee on Cancer Biology at The University of Chicago Pritzker School of Medicine. At The University of Chicago Comer Children’s Hospital, she serves as Director of Pediatric Hematology, Director of the Pediatric Bone Marrow Failure Clinic, and Co-Director of the Pediatric Cancer Genetic Risk Clinic. Her clinical focus includes bone marrow failure, pediatric hematologic disorders, and inherited cancer risk assessment. Her research centers on inherited cancer predisposition, the molecular and genetic mechanisms of bone marrow failure, and hematopoietic stem cell biology. She is also a consortium investigator with the North American Pediatric Aplastic Anemia Consortium. Dr. De Jong has been recognized as a Castle Connolly Regional Top Doctor in Pediatric Hematology-Oncology, named among Castle Connolly’s Exceptional Women in Medicine, and included multiple times in Chicago Magazine’s Top Doctors and Cancer Doctors. She is also a recipient of the University of Chicago’s Pritzker Scholar Award. Dr. De Jong earned both her PhD in Cancer Biology and her MD from the University of Wisconsin. She completed her pediatrics residency at Boston Children’s Hospital, followed by a fellowship in Pediatric Hematology and Oncology at Dana-Farber Cancer Institute and Boston Children’s Hospital.
Associate Professor
Medical School
1999
Residency
1999 – 2002
Fellowship
2002 – 2005